The services leverage technology to speed planning, budgeting and outsourcing
Strategikon Pharma is expanding its Clinical Maestro business operations platform for biopharmaceutical participants with two new offerings, a full-service model and an operator model. The company provides a Software as a Service (SaaS) product license for clinical trial RFP planning and budgeting, which includes implementation and training.
The Clinical Maestro cloud-based platform enables participants in clinical trials—sponsor companies, vendors and service providers—to plan studies, model and manage clinical contracts and outsourcing in a systematic way.
Clinical trial pipelines have been disrupted by delays and changes to trial designs due to the pandemic, increasing the use of remote technologies and tasks, according to the company. Sponsors may find themselves swamped with budgeting and planning, while short on time or resources.
A new ‘operator’ model consists of assigning trained experts to assist, or directly operate Clinical Maestro to expedite the output delivery. The model is geared towards biopharmaceutical sponsors who operate at high speed and may not have the trained staff available or the time to run clinical plans, budgets or RFPs in the cloud-based platform. In such cases, Strategikon will work remotely to deliver the outputs required.
The ‘full service’ model, optimized for small biotechnology companies with limited resources and a small pipeline, performs the analysis on Strategikon's internal system and provides the sponsor with a baseline budget and alternative scenarios, depending upon the sponsor's requirement. The option allows the sponsor to develop a budget and scenarios without investing in software licensing and personnel training.
Strategikon Pharma, developer of the Clinical Maestro service, is headquartered in San Rafael, CA.